Skip to content
Get alerts
GovInfoNow
Use caution Drug recall · FDA · Published March 24, 2015

Nomax Recalls Rose Bengal GloStrips Due to Dosage Issues

Nomax Inc recalls Rose Bengal GloStrips USP due to failed content uniformity. Check lot numbers and expiration dates for affected batches.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0962-2015DrugNomax Inc ›
Take action

Contact the company

Recalling firmNomax Inc9735 Green Park Industrial Dr · Saint Louis, MO 63123-7241
✎ GovInfoNow plain-language explainer

Nomax Inc is recalling Rose Bengal GloStrips because the packaging degradation may cause the strips to not meet dosage specifications. This means the amount of rose bengal in the strips might be inconsistent. The recall affects specific lots distributed nationwide and internationally. Read more at govinfonow.com/recall/44822-nomax-inc-recalls-rose-bengal-glostrips-rose-bengal-ophthalmic-strips.

Source Summary by GovInfoNow · govinfonow.com/recall/44822-nomax-inc-recalls-rose-bengal-glostrips-rose-bengal-ophthalmic-strips · Updated October 12, 2026 · FDA enforcement record: FDA #D-0962-2015

Cite this page

“Nomax Recalls Rose Bengal GloStrips Due to Dosage Issues.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/44822-nomax-inc-recalls-rose-bengal-glostrips-rose-bengal-ophthalmic-strips. Based on FDA recall #D-0962-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0962-2015%22&limit=1).

The FDA announced on March 24, 2015, that Nomax Inc voluntarily recalled Rose Bengal GloStrips Ophthalmic Strips due to failed content uniformity specifications. The agency stated the product may not meet release specifications because of packaging degradation affecting dosage levels.

How to tell if you have it

  • Brand: Nomax Inc
  • Product: Rose Bengal GloStrips (rose bengal) Ophthalmic Strips USP, 1.3 mg per strip
  • NDC: 51801-004-01, 51801-004-40
  • UPC: 3 51801 00440 8
  • Lot codes: 8925 (Exp 07/17), 8972 (Exp 10/17), 9195 (Exp 04/18)
  • Quantity: 5,514 cartons

The hazard

The FDA said the product may not meet finished product release specifications, including the uniformity of dosage. This issue stems from packaging degradation related to the adhesive component of the paper pouch, which can impact the level of rose bengal present in the strips.

Context

GovInfoNow's records show Nomax Inc has two other recalls on record since April 13, 2021. On April 19, 2024, the company recalled Nomax FUL-GLO Ophthalmic Strips due to impurities that may affect safety. On April 13, 2021, Nomax Dry Eye Test Strips were recalled for being a subpotent drug hazard. Other recent recalls of similar products include Max Packaging Antibacterial Towelettes (Jan. 20, 2026).

How to tell if you have this one

Look for Rose Bengal GloStrips (rose bengal) Ophthalmic Strips USP, 1.3 mg per strip. Check if the lot number is 8925 (Exp 07/17), 8972 (Exp 10/17), or 9195 (Exp 04/18). The product has NDC 51801-004-01 and UPC 3 51801 00440 8.

  • Brand
    Nomax Inc
  • Product
    Rose Bengal GloStrips (rose bengal) Ophthalmic Strips USP, 1.3 mg per strip, individually wrapped strip (NDC
  • Category
    Drug
FDA recall event · 3 products

All 3 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class III
  • Status
    Terminated
  • Distribution
    Nationwide and Puerto Rico, Australia, Brazil, Canada, Chile, Colombia, Dominican Republic, Honduras, Iceland, Israel, Jamaica, Trinidad and Tobago, and St. Lucia
Recall numberProduct, codes & lotsQuantityNDC
D-0961-2015Fluorescein Sodium Ophthalmic Strips USP, 0.6 mg per strip, labeled as 1) Fluorescein GloStrips, individually wrapped strip (NDC 51801-003-01), barcode (01)00351801003012, packaged in a) 100-count strips per carton (NDC 51801-003-40, UPC 3 51801 00340 1); and b) 300-count strips per carton (NDC 51801-003-50, UPC 3 51801 00350 0), Nomax, Inc., St. Louis, MO 63123 USA; and 2) FUL-GLO, individually wrapped strip (NDC 1748-403-03), barcode (01)00317478403036, packaged in 300-count strips per carton (NDC 17478-403-030, UPC 3 17478-403-03 6), Manufactured for: Akorn, Inc., Lake Forest, IL 60045.; 1) GloStrips Lot: a) 9031, Exp 12/17; b) 9023, Exp 11/17; 9065, Exp 01/18; 9127 and 9132, Exp 03/18; and 2) Ful-Glo Lot: 9050, Exp 12/18; 9113, Exp 02/19; and 9206, Exp 05/1923,201 cartons51801-003-50, 51801-003-40, 51801-003-01, 0035180100, 0031747840, 17478-403-03
D-0962-2015Rose Bengal GloStrips (rose bengal) Ophthalmic Strips USP, 1.3 mg per strip, individually wrapped strip (NDC 51801-004-01), barcode (01)00351801004019, packaged in 100-count strips per carton (NDC 51801-004-40, UPC 3 51801 00440 8), Nomax, Inc., St. Louis, MO 63123 USA.; Lot #: 8925, Exp 07/17; 8972, Exp 10/17; and 9195, Exp 04/185,514 cartons51801-004-40, 51801-004-01, 0035180100
D-0963-2015Fluorescein Sodium Ophthalmic Strips USP, 1.0 mg per strip, labeled as 1) FUL-GLO, individually wrapped strips, barcode (01)00317478404019; packaged in 100-count strips per carton, (NDC 17478-404-01), UPC 3 17478 40401 9, Manufactured for: Akorn, Inc., Lake Forest, IL 60045.; and 2)Fluorescein Pro Glo Strips, individually wrapped strips, barcode (01)00360843000026, packaged in 300-count strips per carton, (NDC 60843-300-50), UPC 3 60843 30050 8, Manufactured for Eye Care and Cure by Nomax, Inc., St. Louis, MO 63123.; 1) FUL-GLO Lot: 8980, Exp 10/15; 9081, Exp 01/16; 9088, Exp 02/16; 9128 and 9158, Exp 03/16; 2) Pro Glo Lot: 9082, Exp 01/1762,691 cartons—
Based on the official FDA remedy

What to do — step by step

  1. Check Your Lot Number

    Verify if your product matches lot numbers 8925, 8972, or 9195 with the specified expiration dates.

  2. Contact Nomax Inc

    Since no remedy is stated in the record, contact Nomax Inc directly for further instructions on what to do with the product.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Nationwide and Puerto Rico, Australia, Brazil, Canada, Chile, Colombia, Dominican Republic, Honduras, Iceland, Israel, Jamaica, Trinidad and Tobago, and St. Lucia” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA terminated this recall 23 months after the firm started it.

1. Firm started the recall: Mar 24, 201512. FDA classified it Class III: Apr 21, 201523. Published in FDA’s Enforcement Report: Apr 29, 201534. FDA terminated the recall: Feb 21, 2017420152017
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

From the GovInfoNow team · based on the FDA notice · How we make summaries

Where was this product sold?

Distribution included nationwide and Puerto Rico, as well as Australia, Brazil, Canada, Chile, Colombia, Dominican Republic, Honduras, Iceland, Israel, Jamaica, Trinidad and Tobino, and St. Lucia.

Similar recalls

American Health Packaging Recalls Metoclopramide Tablets Due to Foreign Drug Presence
American Health PackagingTeva Recalls Metoclopramide Tablets Due to Foreign Contaminants
Teva Pharmaceuticals USA, IncPreferred Pharma Recalls Lidocaine Ointment Due to Content Issues
Preferred Pharmaceuticals, Inc.Northstar Rx Recalls Tretinoin Cream Due to Impurities
SUN PHARMACEUTICAL INDUSTRIES INCApothecary Pharma Recalls Tirzepatide Injections Due to Sterility Risk
Apothecary Pharma LLC

Latest drug recalls

Apotex Corp. recalls Paroxetine Extended-Release Tablets, 37.5mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario,
Apotex · September 23, 2026Cipla USA, Inc. recalls Fosfomycin Tromethamine Granules for Oral Solution, (Equivalent to 3 Grams of Fosfomycin), 1 Single-Dose Sachet, Rx
Cipla USA · September 18, 2026Ajanta Pharma USA Inc recalls Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc.,
Ajanta Pharma · September 17, 2026Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company recalls Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) with
Insight Pharmaceuticals · September 15, 2026K.C. Pharmaceuticals, Inc. recalls Sterile Lubricant Dry Eye Relief Eye Drops, 0.5 FL OZ (15 mL); a) LEADER, DISTRIBUTED BY CARDINAL HEALTH, DUBLIN, OHIO
Leader / TopCare / Crocodile Tears · September 11, 2026Amneal Pharmaceuticals, LLC recalls Estradiol Gel, 0.1%, 0.25 mg, 30-packets per carton, Rx only, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater,
Amneal Pharmaceuticals · September 8, 2026

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0962-2015 (March 24, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0962-2015 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA